Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation (3T-CO)
Chronic Obstipation
About this trial
This is an interventional treatment trial for Chronic Obstipation focused on measuring Exercise Therapy, Biofeedback (Psychology), Adult, Chronic Obstipation/*therapy, EMG - Biofeedback, EMG - Triggered Stimulation, Augmented biofeedback
Eligibility Criteria
Inclusion Criteria:
- All Patients with chronic obstipation (Rom criteria II)
Exclusion Criteria:
- Chronic inflammatory bowel disease, systemic peripheral neuropathy (MS, diabetes), disorders of enteric nervous system (Hirschsprung disease, chagas, IND, myopathy desmosis coli), idiopathic megacolon/megarectum, patients with mental or intellectual deficits.
Sites / Locations
- University of Gießen, Dept. of General SurgeryRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Triple Target Treatment
EMG-biofeedback alone
In the 3T arm, patients were stimulated with a carrier wave of 25 KHz and biphasic modulations of the pulse train of 40 Hz. Anxious patients trained at first only in the biofeedback mode. The stimulation was introduced after four weeks for these patients. Patients were instructed to carry out the training at home, with an alternating combination in the morning and with EMG-triggered stimulation in the evening, each for 20-minute periods. Apart from this, the protocol of the active treatment group was identical to that of the control group.
In the biofeedback arm, patients were instructed to carry out EMG-biofeedback training at home, standing, mornings and evenings, for 20-minute periods. The core of the task was to pull the plug-electrode upward inside the anal channel, like a lift, and to hold it there during varying periods of tension. This can only be done successfully if the perineum rises and at the same time the puborectal muscle is activated. Just squeezing the sphincter muscles does not produce this lifting effect.